Señales en vivo de ATHX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 ene 2024 @ 15:58):

Stats
Volumen de hoy	6.46M
Volumen promedio	1.77M
Capitalización de mercado	833 204
EPS	$0 ( 2024-03-29 )
Próxima fecha de ganancias	( $0 ) 2024-05-16
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.00818
ATR14	$0.00600 (26.55%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-18	Hansen Maia	Sell	67	Common Stock
2023-10-04	Hansen Maia	Sell	23 149	Common Stock
2023-10-04	Camardo Daniel A.	Sell	19 993	Common Stock
2023-09-18	Hansen Maia	Sell	67	Common Stock
2023-08-17	Mayhugh Neema	Buy	27 428	NonQualified Stock Option (right to purchase)

INSIDER POWER
23.17
Last 94 transactions
Buy: 8 476 520 \| Sell: 1 272 175

Volumen Correlación

Largo: -0.02 (neutral)

Corto: 0.37 (neutral)

Signal:(49.051) Neutral

Athersys Inc Correlación

10 Correlaciones Más Positivas
ADN	0.951
INVZ	0.95
ARVL	0.946
ATNF	0.946
KZR	0.944
CAAS	0.943
MPAA	0.94
BPYPN	0.939
PETS	0.939
MMAT	0.939

10 Correlaciones Más Negativas
NVCN	-0.951
STAY	-0.929
TIOA	-0.926
AVEO	-0.924
VCXA	-0.921
XM	-0.92
PCRX	-0.919
BRIVU	-0.919
ITMR	-0.915
ENER	-0.914

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Athersys Inc Correlación - Moneda/Commodity

-0.55
( weak negative )

-0.46
( neutral )

0.00
( neutral )

-0.59
( weak negative )

-0.18
( neutral )

0.26
( neutral )

Athersys Inc Finanzas

Annual	2022
Ingresos:	$5.33M
Beneficio Bruto:	$5.33M (100.00 %)
EPS:	$-5.70

FY	2022
Ingresos:	$5.33M
Beneficio Bruto:	$5.33M (100.00 %)
EPS:	$-5.70

FY	2021
Ingresos:	$5 514.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$0

FY	2020
Ingresos:	$1.44M
Beneficio Bruto:	$1.44M (100.00 %)
EPS:	$-0.420

Financial Reports:

No articles found.

Athersys Inc

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients, including those suffering from serious conditions with unmet medical needs. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio.